TNF Pharmaceuticals ( (TNFA) ) has released a notification of late filing.
Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
TNF Pharmaceuticals has announced a delay in filing its Annual Report on Form 10-K (Yearly Report) for the financial period ending December 31, 2024. The primary reason for this delay is the additional time required to complete and finalize the financial statements. The company anticipates that the report will be filed within 15 calendar days following the original due date. Importantly, TNF Pharmaceuticals does not expect any significant changes in its financial results for the period. The notification was signed by Joshua Silverman, Director, who assured ongoing compliance efforts.
More about TNF Pharmaceuticals
YTD Price Performance: -68.70%
Average Trading Volume: 533,938
Technical Sentiment Signal: Strong Buy
Current Market Cap: $991.8K
Find detailed analytics on TNFA stock on TipRanks’ Stock Analysis page.